|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.87 CNY | -5.08% |
|
+8.09% | -44.67% |
Ningxia Zhongke Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 606.12 million compared to CNY 192.41 million a year ago. Net loss was CNY 21.42 million compared to CNY 103.51 million a year ago.
Basic loss per share from continuing operations was CNY 0.031 compared to CNY 0.151 a year ago. Diluted loss per share from continuing operations was CNY 0.031 compared to CNY 0.151 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -44.67% | 186M | |
| +3.47% | 103B | |
| -8.02% | 61.43B | |
| +72.86% | 48.84B | |
| +15.48% | 38.62B | |
| +3.64% | 31.72B | |
| +13.29% | 20.15B | |
| +12.53% | 16.67B | |
| +15.34% | 14.67B | |
| +0.39% | 13.79B |
NINGXIA ZHONGKE BIOTECHNOLOGY CO., LTD 
